| Home > Zentren > Zentrum für Innere Medizin > I. Medizinische Klinik und Poliklinik > Publikationen > 2000
Bläker M, Ren Y, Sundararajan L, McBride E W, Beinborn M, Kopin AS:
CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides.
Mol Pharmacol 2000; 58: 399-406
http://www.ncbi.nlm.nih.gov/sites/entrez/10908308
Block A., Freund C., Chen S.-H., Nguyen K.-P., Finegold M., Windler, E., Woo S.L.C.
Gene Therapy of metastatic colon carcinoma: Regression of multiple hepatic metas0tasis by adenoviral expression of bacte0rial cytosine deaminase
Cancer Gene Therapy 2000; 7 (3): 438-45
http://www.ncbi.nlm.nih.gov/sites/entrez/10766350
Buggisch P:
Kombinationstherapien für die Hepatitis C
Hamburger Ärzteblatt 2000; 1: 8-10
Dandri M, Burda M, Will H, and Petersen J:
Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the covalently closed circular DNA.
Hepatology 2000; 32: 139-146
http://www.ncbi.nlm.nih.gov/sites/entrez/10869302
Dandri M, Burda H, Will H, Petersen J:
Animal models of Hepadnavirus Infection.
A review. Viral Hepatitis Reviews 2000; 6: 29-45
Fischer L, Sterneck M, Gahlemann C, Malagó M, Rogiers X, Broelsch CE.:
A Prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients
Transplantation Proceedings 2000;32(7):2125-2127
http://www.ncbi.nlm.nih.gov/sites/entrez/11120098
Fischer L, Sterneck M, Zöllner B, Rogiers X.:
Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation
Transplantation Proceedings 2000;32(7):2128-2130
http://www.ncbi.nlm.nih.gov/sites/entrez/11120099
Freund C., Tong X.-W., Block A., Contant C.F., Chen S. H., Dang T., Kieback D.G., Rowley D.R., Woo S.L.C. and Lerner S.P:
Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and rous sarcoma virus-promoter to drive thymidine kinase gene, Anticancer Res 2000; 20: 2811-6
http://www.ncbi.nlm.nih.gov/sites/entrez/11062688
Gundlach M, Broering D, Topp S, Sterneck M, Rogiers X.:
Split-cava technique: liver splitting for two adult recipients
Liver Transplantation 2000;6(6):703-706
http://www.ncbi.nlm.nih.gov/sites/entrez/11084054
Heike M, Frenzel C, Meier D, Galle PR:
Expression of stress protein gp96, a tumor rejection antigen, in human colorectal cancer.
Int J Cancer 2000; 15; 86: 489-93
http://www.ncbi.nlm.nih.gov/sites/entrez/10797260
Helmreich-Becker I, Maeurer M, Galle PR, Lohse AW:
Granulomatous hepatitis in an immunocompromised patient diagnosed by minilaparoscopy.
Endoscopy 2000; 32: 27-28
http://www.ncbi.nlm.nih.gov/sites/entrez/10817195
Herkel J, Erez-Alon N, Wolkowicz R, Harmelin A, Ruiz P, Rotter V, Cohen IR:
Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the carboxy-terminal domain of p53 that recognizes damaged DNA.
Eur J Immunol 2000; 30: 977-984.
http://www.ncbi.nlm.nih.gov/sites/entrez/10760784
Hoehler T, Lohse AW, Schirmacher P:
Progressive nodular hyperplasia of the liver in a patient with genetic hemochromatosis - growth promotion by iron overload?
Dig Dis Sci 2000; 45: 587-590
http://www.ncbi.nlm.nih.gov/sites/entrez/10749337
Löhr H, Schlaak JF, Lohse AW, Böcher WO, Kanzler S, Ibe M, Galle PR:
How long to treat chronic hepatitis B virus infection with lamivudine?
J Hepatol 2000; 33: 343
http://www.ncbi.nlm.nih.gov/sites/entrez/10952257
Pons M, Ihrke G, Koch S, Biermer M, Pol A, Grewal T, Jackle S, Enrich C:
Late endocytic compartments are major sites of annexin VI localization
in NRK fibroblasts and polarized WIF-B hepatoma cells.
Exp Cell Res 2000; 257: 33-47
http://www.ncbi.nlm.nih.gov/sites/entrez/10854052
Schramm C, Schlaak JF, Galle PR:
Rapid development of Epstein-Barr virus-associated Hodgkin's disease after cessation of foscarnet therapy in an HIV-infected patient.
Int J STD AIDS 2000; 11: 609-10
http://www.ncbi.nlm.nih.gov/sites/entrez/10997507
Sterneck M, Fischer L, Gahlemann C, Gundlach M, Rogiers X, Broelsch CE.:
Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial
Annals of Transplantation 2000;5:43-46
http://www.ncbi.nlm.nih.gov/sites/entrez/10850611
Sterneck M.:
Ätiologie des hepatozellulären Karzinoms. Das Problem der Grunderkrankung
Internist 2000;41:185-190
Von Schrenck T, Ahrens M, de Weerth A, Bobrowski C, Wolf G, Jonas L, Jocks T, Schulz M, Bläker M, Neumaier M, Stahl AK:
CCKB/gastrin receptors mediate changes in sodium and potassium absorption in the isolated perfused rat kidney.
Kidney International 2000; 58: 995-1003
http://www.ncbi.nlm.nih.gov/sites/entrez/10972664
Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Büschenfelde KH, Lohse AW:
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
Lancet 2000; 355: 1510-1515
http://www.ncbi.nlm.nih.gov/sites/entrez/10801173
Wilkens L, Benten D, Tchinda J, Brabant G, Potter E, Dralle H, von Wasielewski R:
Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation.
Virchows Arch 2000; 436: 312-8
http://www.ncbi.nlm.nih.gov/sites/entrez/10834532
Zeuzem S., Feinman V., Rasenack J., Heathcote J., Lai M-Y., Gane E., O´Grady J., Reichen J.,Diago M., Lin A., Hoffmann J.,Brunda M.J. and the study group:
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C.
NEJM 2000; 343: 1666-1672
http://www.ncbi.nlm.nih.gov/sites/entrez/11106715
